HK Stock Market Move | MEITU(01357) increased by nearly 4%, AI Agent topped the domestic App Store category list, and the net profit for the first half of the year is expected to increase significantly after adjustment.
Meitu Inc. (01357) rose nearly 4%, as of the time of publication, it increased by 3.76% to HK$11.04, with a turnover of HK$252 million.
MEITU (01357) rose nearly 4%, as of the time of writing, it has risen by 3.76% to HKD 11.04, with a trading volume of 2.52 billion Hong Kong dollars.
On the news front, it was reported that MEITU's AI Agent "RoboNeo", released recently, topped the domestic App Store category rankings on July 22nd. RoboNeo, as an AI intelligent entity focusing on imagery and design, stands out for its natural language interaction empowering visual creation, greatly reducing the threshold for professional creation. In addition, MEITU recently announced positive earnings, with adjusted net profit attributable to equity holders of the parent company in the first half of 2025 potentially increasing by about 65% to 72% year-on-year according to non-IFRS.
Morgan Stanley released a research report stating that they have significantly raised MEITU's target price by 140%, from HKD 6.00 to HKD 14.40, while maintaining a "Hold" rating. Morgan Stanley believes that the AI design software RoboNeo launched by Meitu this month and the existing features of Meitu mark the beginning of Meitu's entry into the global e-commerce design market. Morgan Stanley has raised long-term forecasts for monthly active users (MAU), penetration rate of paid users, and average revenue per paying user (ARPPU), stating that execution remains the key to achieving higher growth.
Related Articles

PURAPHARM (01498) is planning to issue 46.512 million shares to BAGI Research Limited, raising approximately HK$2000.02 million.

STARPLUS LEGEND (06683) plans to offer a discount of approximately 19.91% to existing shareholders for a rights issue, with a maximum net proceeds of around HK$324 million.

BAIJIN LIFE SCI (01466) released its annual results with a shareholder loss of HK$316,000, a decrease of 95.76% year-on-year.
PURAPHARM (01498) is planning to issue 46.512 million shares to BAGI Research Limited, raising approximately HK$2000.02 million.

STARPLUS LEGEND (06683) plans to offer a discount of approximately 19.91% to existing shareholders for a rights issue, with a maximum net proceeds of around HK$324 million.

BAIJIN LIFE SCI (01466) released its annual results with a shareholder loss of HK$316,000, a decrease of 95.76% year-on-year.

RECOMMEND

After Eight Consecutive Rate Cuts, the European Central Bank Pauses as Expected; Future Policy Direction Remains Murky
25/07/2025

U.S. President Makes First Official Visit to the Federal Reserve in Nearly 20 Years—What Did Trump and Powell Say?
25/07/2025

New Categories of Air Conditioners in Short Supply, Sales of Ice-Packed Handheld Fans Surge, China’s “Cooling Big Four” Explode in Popularity Across Europe
25/07/2025